Alexander Hardy Salary and Compensation - BIOMARIN PHARMACEUTICAL INC CEO Pay 2025

In fiscal year 2025, Alexander Hardy, President and CEO of BIOMARIN PHARMACEUTICAL INC (BMRN), received total compensation of $21.9 million.

Alexander Hardy's compensation breakdown includes: base salary of $1.1 million, stock awards valued at $16.8 million, option awards of $1.9 million, non-equity incentive compensation of $1.6 million, and other compensation of $409K.

Compared to fiscal year 2024, Alexander Hardy's total compensation increased 48% from $14.9 million to $21.9 million.

BIOMARIN PHARMACEUTICAL INC (BMRN) Executive Pay 2025

BIOMARIN PHARMACEUTICAL INC's top 5 named executive officers received combined total compensation of $47.3 million in fiscal year 2025.

The named executive officers disclosed in BIOMARIN PHARMACEUTICAL INC's 2025 proxy statement are:Alexander Hardy (President and CEO) with total compensation of $21.9 million, Gregory R. Friberg (M.D. Executive Vice President, Chief Research & Development Officer) with total compensation of $7.2 million, Brian R. Mueller (Executive Vice President CFO) with total compensation of $6.8 million, Cristin Hubbard (Executive Vice President Chief Commercial Officer) with total compensation of $5.7 million, and C. Greg Guyer (Ph.D. Executive Vice President, Chief Technical Officer) with total compensation of $5.7 million.